about
The A(2A)-adenosine receptor: a GPCR with unique features?Defining the blanks--pharmacochaperoning of SLC6 transporters and ABC transportersOxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand designOligomerization of the {gamma}-aminobutyric acid transporter-1 is driven by an interplay of polar and hydrophobic interactions in transmembrane helix IIA kinase-independent function of CDK6 links the cell cycle to tumor angiogenesisTruncation of the A1 adenosine receptor reveals distinct roles of the membrane-proximal carboxyl terminus in receptor folding and G protein couplingA multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinitiesOligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells.STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior.Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptorsG protein antagonists.Spectrum of Cav1.4 dysfunction in congenital stationary night blindness type 2The N terminus of monoamine transporters is a lever required for the action of amphetaminesCalmodulin dependence of presynaptic metabotropic glutamate receptor signaling.G protein-dependent signalling and ageing.The role of zinc ions in reverse transport mediated by monoamine transporters.The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter.Molecular dissection of dual pseudosymmetric solute translocation pathways in human P-glycoprotein.PI3Kδ is essential for tumor clearance mediated by cytotoxic T lymphocytes.Inhibition of receptor/G protein coupling by suramin analogues.In vivo amphetamine action is contingent on αCaMKIIAdenosine receptors: G protein-mediated signalling and the role of accessory proteins.Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology modelConcentrative export from the endoplasmic reticulum of the gamma-aminobutyric acid transporter 1 requires binding to SEC24D.The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transportersThe serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C.Platelet serotonin transporter function predicts default-mode network activityPharmacological correction of misfolding of ABC proteins.Oligomer formation by Na+-Cl--coupled neurotransmitter transporters.Probing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells.Unifying concept of serotonin transporter-associated currentsAmphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII.Refinement of the Central Steps of Substrate Transport by the Aspartate Transporter GltPh: Elucidating the Role of the Na2 Sodium Binding SitePeptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies.Signal-dependent export of GABA transporter 1 from the ER-Golgi intermediate compartment is specified by a C-terminal motifAxonal targeting of the serotonin transporter in cultured rat dorsal raphe neurons is specified by SEC24C-dependent export from the endoplasmic reticulumAmphetamines, new psychoactive drugs and the monoamine transporter cycle.Sec24- and ARFGAP1-dependent trafficking of GABA transporter-1 is a prerequisite for correct axonal targeting.Chaperoning of the A1-adenosine receptor by endogenous adenosine - an extension of the retaliatory metabolite concept.The Environment Shapes the Inner Vestibule of LeuT.
P50
Q24653743-75EA510C-84CD-4C78-9E93-E7AB9351F680Q26825537-02FAE4ED-9424-4085-AAB6-0E12103A25FEQ27680631-69CD2A07-9FE7-42FE-B476-4114BBA687B7Q28288845-278FAEDE-4261-419C-A0ED-0572700108E9Q28296641-6F12A37D-9724-4541-8AA4-E878EE448C2BQ28578759-C8531C3E-3654-4F88-8ACC-8B67F55F2D94Q30657759-56038BF1-4D11-48EF-983A-97FF0A39087DQ31546930-30E05BFD-50ED-4282-8A50-7EA5FE880960Q33562339-644AE257-821E-4553-8B5D-A7C757F7C98FQ33650270-155CB9E4-02A4-47D5-A860-767C996F765EQ33656580-4966BA24-B9B7-4BA6-B308-FA2343474167Q33786236-4D7B91EC-9111-49E0-98B0-F7F84799FAB0Q33796294-060008C7-4F7B-4C0E-94E7-D7D9B09C6D0EQ33879190-B807CE9E-FD78-4769-B86F-B098F401CD71Q33892776-2CBAB6B3-9FB7-4547-8C5D-803312110D0AQ34122719-CE67FE99-71B0-4A3B-BBB4-E7D27594EE6AQ34137102-B50CC72E-3916-488F-9560-6563F2CFF2F3Q34156111-B308BFCB-D208-4501-8BE3-F48AB25DB030Q34342465-B92BF83A-054D-407C-9E41-4E3BD0017EA3Q34388145-D90DAE7C-E5F8-487F-8D2C-8C9DA3C6EB7CQ34393113-E9F0CA2F-EA02-4554-9A6A-ACA07AA8B66CQ34487172-B11C9701-8881-4427-8C89-89713B6FFCE1Q34597890-B879EFF9-C6E5-4041-98CE-5761FAF7ED19Q34599412-ED5B7BB3-66B4-4925-846B-959CDD40A51CQ34660686-4BAB315A-2B01-4D8A-A87B-E2895E1CB35FQ34963789-628A76FA-42A2-4B86-8197-41E1287D567DQ35131170-25C6A2E8-FA62-454C-9BD0-CE1531CEEA6CQ35207294-B368B7D1-715C-4086-B6C2-708987A0A30BQ35581539-44ACDFDB-C050-4181-9A10-883E16C0ECE6Q35643579-81752323-FE1F-4E04-943A-4006FA93BFC3Q35643721-606755D5-E588-4DD9-8B49-555B159C0FB9Q35649527-9BD0FE13-A369-4253-9EA7-F5C5AEA67B8BQ35814637-160487CB-94A6-4FE8-8CB0-98131A9B7493Q35825535-B103152D-9604-4235-A024-5078E94E0773Q35836287-6230AD64-C796-473F-AA0A-9B23B4CFD348Q35836300-E339CD19-DF67-4BF8-B202-F9542BB1686AQ35853599-ABBC7304-9464-4BA3-B26D-7D6E9FD0AF3DQ35854905-725EC759-38C0-484C-AFEA-A7B26EED15F9Q35885389-0BDB584A-D34B-49B5-9876-7625163F7579Q36189760-BCF225D9-FCD3-4DE9-B982-414B729DA5B7
P50
description
researcher ORCID ID = 0000-0001-9398-1765
@en
wetenschapper
@nl
name
Michael Freissmuth
@ast
Michael Freissmuth
@en
Michael Freissmuth
@es
Michael Freissmuth
@nl
type
label
Michael Freissmuth
@ast
Michael Freissmuth
@en
Michael Freissmuth
@es
Michael Freissmuth
@nl
altLabel
Freissmuth M
@en
prefLabel
Michael Freissmuth
@ast
Michael Freissmuth
@en
Michael Freissmuth
@es
Michael Freissmuth
@nl
P106
P31
P496
0000-0001-9398-1765